General
What does each manufacturing profile contain?
Each profile follows a canonical structure: synthesis methodology (SPPS chemistry, resin selection, coupling reagents), purification (preparative RP-HPLC, gradient design, fraction acceptance criteria), analytical release testing (ICH Q2-validated methods for identity, purity, content, residual solvents, endotoxin, bioburden), lyophilization cycle parameters, stability program design per ICH Q1A(R2), batch documentation framework, and supply-chain qualification notes.
Are the specifications pharmaceutical-grade?
Yes. Specifications are written to reflect industry-standard practice for cGMP peptide manufacturing under FDA 21 CFR Parts 210 and 211, ICH Q7 active ingredient GMP, and applicable ICH Q-series quality guidelines. They are reference specifications; users must adapt numerical parameters to qualified site-specific equipment and validated processes.
What synthesis methodologies are documented?
Profiles primarily document Fmoc-based solid-phase peptide synthesis on Wang, Rink, 2-chlorotrityl, or sequence-appropriate resins. Boc chemistry, fragment condensation, and convergent liquid-phase strategies are referenced for peptides where they remain industry-standard.
Technical Specifications
Which analytical methods are covered?
Identity by ESI-MS or MALDI-TOF; purity by reversed-phase HPLC with UV detection; content determination by amino acid analysis and quantitative UV; residual solvents by GC-headspace per ICH Q3C; water content by Karl Fischer; counter-ion analysis where applicable; endotoxin by USP <85> LAL; bioburden by USP <61> and <62>.
Are stability protocols included?
Yes. Each profile references a stability program design aligned with ICH Q1A(R2): accelerated conditions (25 deg C / 60% RH and 40 deg C / 75% RH), long-term storage at -20 deg C, stability-indicating analytical method, and degradation pathway characterization.
Which quality standards are referenced?
Primary references include 21 CFR Parts 210/211 (cGMP), ICH Q7 (active ingredient GMP), ICH Q8(R2)/Q9/Q10 (pharmaceutical development and quality systems), ICH Q1A(R2) (stability), ICH Q2(R1) (analytical validation), ICH Q3A/Q3B/Q3C (impurity qualification), USP general chapters, and ISO 9001:2015 QMS principles.
Documentation Access
How do I navigate to a specific profile?
Use the Manufacturing menu in the top navigation or the complete catalog on the sitemap page. Profiles are grouped alphabetically and named consistently as "[peptide]-mfg.html".
Can I request additional documentation?
Yes. Contact the relevant documentation desk via the contact page. Custom-specification questions, citation requests, or regulatory framework clarifications are routed to the appropriate subject-matter desk.
Are process validation protocols available?
Process validation considerations are referenced within each profile under the synthesis and analytical sections. Full validation master plans, IQ/OQ/PQ documentation, and protocol templates are out of scope for the public library and available through direct technical inquiry.
For questions not covered here, contact the relevant documentation desk.